Pfizer India (PFIZER) Q1 24/25 earnings summary

Executive summary

• Unaudited financial results for the quarter ended June 30, 2024, were approved by the Board on July 29, 2024.

• Results prepared in accordance with Ind AS and SEBI regulations.

Financial highlights

• Revenue from operations for Q1 FY25 was ₹562.86 crore, up from ₹531.36 crore in Q1 FY24.

• Total income for the quarter was ₹604.70 crore, compared to ₹564.82 crore in the same quarter last year.

• Net profit for the quarter was ₹150.71 crore, up from ₹93.53 crore year-over-year.

• Earnings per share (EPS) for the quarter stood at ₹32.94, compared to ₹20.44 in Q1 FY24.

• Profit before tax was ₹202.62 crore, up from ₹125.75 crore in the same quarter last year.

Key financial ratios and metrics

• Gross margin improved as total expenses were ₹402.08 crore versus ₹439.07 crore in Q1 FY24.

• EPS before exceptional items was ₹32.94 for the quarter.